#Isomorphic Labs
3 articles with this tag
Demis Hassabis's Isomorphic Labs: $2.7B Raised, Trials Due This Year
Isomorphic Labs raised $2.7B total through May 2026. How the pharma deals with Lilly and Novartis work, what IsoDDE changed, and when trials begin.
Architectural Interactivity, Linguistic Interpretability, and Molecular Synthesis: The Frontier of Native AI
Three organisations now define the frontier of native AI: Thinking Machines is rebuilding human-AI collaboration as a low-latency interaction model, the Effable movement wants interpretable safety frameworks like SafetyAnalyst, and Isomorphic Labs is converting AlphaFold into an end-to-end drug design engine. The common thread is moving from AI as a layer of abstraction toward AI as a fundamental component of human and biological systems.
Demis Hassabis in 2026: How DeepMind Is Turning AlphaFold Into a Drug Discovery Engine
Demis Hassabis has spent 2026 arguing that AlphaFold is the first rung in an AI-powered scientific revolution. Here is how his thesis maps to Isomorphic Labs' drug pipeline, DeepMind's research agenda, and his view that the generative AI boom may paradoxically slow deeper progress.